Alkermes (ALKS) ebitda was $380M in FY2025 (-30% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
$380M
-30%
2024
$546M
-8%
2023
$596M
+259%
2022
$166M
-37%
2021
$264M
+343%
2020
$60M
+209%
2019
$19M
-82%
2018
$110M
+218%
2017
$35M
+273%
2016
-$20M
+52%
2015
-$41M
-159%
2014
$71M
-63%
2013
$190M
+1744%
2012
-$12M
+33%
2011
-$17M
-320%
2010
-$4M
Recent Quarterly EBITDA
Quarter
EBITDA
Q2 2026
$72M
Q1 2026
$7M
Q4 2025
$104M
Q3 2025
$114M
Q2 2025
$118M
Q1 2025
$44M
Q4 2024
$204M
Q3 2024
$127M
Q2 2024
$130M
Q1 2024
$84M
Q4 2023
$125M
Q3 2023
$128M
Source: ALKS on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.